𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose–response study

✍ Scribed by CeliaJ.A. Morgan; Ali Mofeez; Brigita Brandner; Lesley Bromley; H.Valerie Curran

Publisher
Springer
Year
2003
Tongue
English
Weight
254 KB
Volume
-1
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gd-DTPA2–-enhanced MRI of femoral knee c
Gd-DTPA2–-enhanced MRI of femoral knee cartilage: A dose-response study in healthy volunteers
✍ Carl J. Tiderius; Lars E. Olsson; Hans de Verdier; Peter Leander; Olle Ekberg; L 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

## Abstract The negatively charged contrast agent Gd‐DTPA^2–^ distributes inversely to the cartilage fixed charged density. This enables structural cartilage examinations by contrast‐enhanced MRI. In line with the development of a clinically applicable protocol for such examinations, this study des

Serotonergic modulation of response inhi
Serotonergic modulation of response inhibition and re-engagement? Results of a study in healthy human volunteers
✍ Barbara Drueke; Maren Boecker; Sonja Schlaegel; Olaf Moeller; Christoph Hiemke; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract ## Objective Cognitive functions dependent on the prefrontal cortex, such as the ability to suppress behavior (response inhibition) and initiate a new one (response re‐engagement) is important in the activities of daily life. Central serotonin (5‐HT) function is thought to be a critica

A placebo-controlled dose response study
A placebo-controlled dose response study of the reactogenicity and immunogenicity of a live cold-recombinant influenza B virus vaccine in healthy volunteers
✍ Dr. U. Ganzinger; H. Bachmayer; E. Liehl; J. J. Martindale; F. Hamilton; Dr. E. 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

A live cold-recombinant influenza B virus vaccine (RB77) was given intranasally in a placebo-controlled, double blind study to volunteers in dosages of 10(7.9) EID50/ml, 10(7.25) EID50/ml, 10(5.7) EID50/ml. The tolerability, safety, and immunogenicity of the vaccine were investigated. No revertant v